share_log

bluebird bio | 8-K: Current report

SEC ·  Jun 24, 2024 20:05

Summary by Futu AI

bluebird bio announced the appointment of Michael Cloonan to its Board of Directors as a Class I director, effective June 20, 2024. The appointment was approved by the company's Board of Directors.As per the company's Non-Employee Director Compensation Policy, Cloonan will receive an annual retainer of $45,000 for his Board service. Additionally, he has been granted an initial equity award consisting of stock options to purchase 74,775 shares of common stock and 37,350 restricted stock units. Both the stock options and restricted stock units will vest equally over a three-year period in annual installments.
bluebird bio announced the appointment of Michael Cloonan to its Board of Directors as a Class I director, effective June 20, 2024. The appointment was approved by the company's Board of Directors.As per the company's Non-Employee Director Compensation Policy, Cloonan will receive an annual retainer of $45,000 for his Board service. Additionally, he has been granted an initial equity award consisting of stock options to purchase 74,775 shares of common stock and 37,350 restricted stock units. Both the stock options and restricted stock units will vest equally over a three-year period in annual installments.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.